Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol for prevention of atrial fibrillation after elective on-pump cardiac surgery
2020-002752-20Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Landiolol hydrochloride with Placebo (2 arms). Started Nov 2020; status: completed.
02
Drugs
landiolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2020-002752-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002752-20.